Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report

被引:3
|
作者
Jung, B. -H. [1 ]
Park, J. -I. [1 ]
Lee, S. -G. [2 ]
机构
[1] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Surg, 875 Haeundae Ro, Busan 48108, South Korea
[2] Univ Ulsan, Asan Med Ctr, Div Hepatobiliary Surg & Liver Transplantat, Dept Surg,Coll Med, Seoul, South Korea
关键词
DRUG-INDUCED HEPATOTOXICITY; RISK-FACTORS; INFECTION; RECIPIENTS; POLYMORPHISMS; MANAGEMENT; HEPATITIS; DIAGNOSIS; THERAPY; FAILURE;
D O I
10.1016/j.transproceed.2018.02.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although active tuberculosis (TB) is considered a contraindication for liver transplantation (LT), this is the only treatment in patients with liver failure and concurrent active TB. We report a case with successful urgent living-donor LT for irreversible liver failure in the presence of active TB. Case Presentation. A 48-year-old man, with a history of decompensated alcoholic liver cirrhosis, was presented with stupor. At admission, his consciousness had deteriorated to semi-coma, and his renal function also rapidly deteriorated to hepatorenal syndrome. A preoperative computed tomography scan of the chest revealed several small cavitary lesions in both upper lobes, and acid-fast bacillus stain from his sputum was graded 2+. Adenosine deaminase levels from ascites were elevated, suggesting TB peritonitis. A first-line anti-TB drug regimen was started immediately (rifampin, isoniazid, levofloxacin, and amikacin). An urgent living-donor LT was performed 2 days later. After LT, the regimen was changed to second-line anti-TB drugs (amikacin, levofloxacin, cycloserine, and pyridoxine). The sputum acid fast bacillus stain tested negative on postoperative day 10. His liver function remained well preserved, even after the reversion to first-line anti-TB treatment. The patient recovered without any anti-TB medication-related complications and was discharged. Conclusions. LT can be prudently performed as a life-saving option, particularly for patients with liver failure and concurrent active TB.
引用
收藏
页码:910 / 914
页数:5
相关论文
共 50 条
  • [1] Living-donor liver transplantation in patients with concurrent active tuberculosis at transplantation
    Lee, Y. T.
    Hwang, S.
    Lee, S-G.
    Kim, K-W.
    Choi, N-K.
    Park, G-C.
    Yu, Y-D.
    Yoo, J-W.
    Kim, W. S.
    Shim, T. S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (08) : 1039 - 1044
  • [2] Living-Donor Liver Transplantation for Hepatic Metastasis From Meningeal Hemangiopericytoma: A Case Report
    Urata, K.
    Ikegami, T.
    Nakazawa, Y.
    Ohno, Y.
    Kobayashi, A.
    Mita, A.
    Sano, K.
    Kurozumi, M.
    Miyagawa, S.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (07) : 2274 - 2277
  • [3] Living-donor liver transplantation for methylmalonic acidemia patient with hepatocellular carcinoma: A case report and literature review
    Deguchi, Harunori
    Sakamoto, Seisuke
    Shimizu, Seiichi
    Fukuda, Akinari
    Uchida, Hajime
    Yanagi, Yusuke
    Nakao, Toshimasa
    Kodama, Tasuku
    Komine, Ryuji
    Nishi, Kentaro
    Kamei, Koichi
    Haga, Chizuko
    Yoshioka, Takako
    Matsumoto, Kimikazu
    Horikawa, Reiko
    Kasahara, Mureo
    PEDIATRIC TRANSPLANTATION, 2024, 28 (02)
  • [4] A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation
    Kawaguchi, Shohei
    Kadono, Yoshifumi
    Nohara, Takahiro
    Kato, Yuki
    Nakagawa, Tomomi
    Urata, Satoko
    Yaegashi, Hiroshi
    Nakashima, Kazufumi
    Iijima, Masashi
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Mizokami, Atsushi
    UROLOGIA INTERNATIONALIS, 2020, 104 (1-2) : 160 - 162
  • [5] Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report
    Sofue, Tadashi
    Hayashida, Yushi
    Hara, Taiga
    Kawakami, Kazuyo
    Ueda, Nobufumi
    Kushida, Yoshio
    Inui, Masashi
    Dobashi, Hiroaki
    Kakehi, Yoshiyuki
    Kohno, Masakazu
    BMC NEPHROLOGY, 2014, 15
  • [6] Thrombotic Microangiopathy After Living-Donor Liver Transplantation
    Shindoh, J.
    Sugawara, Y.
    Akamatsu, N.
    Kaneko, J.
    Tamura, S.
    Yamashiki, N.
    Aoki, T.
    Sakamoto, Y.
    Hasegawa, K.
    Kokudo, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 728 - 736
  • [7] Leukoencephalopathy Syndrome After Living-donor Liver Transplantation
    Umeda, Yuzo
    Matsuda, Hiroaki
    Sadamori, Hiroshi
    Shinoura, Susumu
    Yoshida, Ryuichi
    Sato, Daisuke
    Utsumi, Masashi
    Yagi, Takahito
    Fujiwara, Toshiyoshi
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (02) : 139 - 144
  • [8] Pseudomonas aeruginosa infection after living-donor liver transplantation in adults
    Hashimoto, M.
    Sugawara, Y.
    Tamura, S.
    Kaneko, J.
    Matsui, Y.
    Kokudo, N.
    Makuuchi, M.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (01) : 11 - 19
  • [9] Living Donor Liver Transplantation in a Patient With Extensive Portomesenteric Venous Thrombosis: Case Report
    Choi, S.
    Kim, K. K.
    Lee, W. S.
    Kang, J. M.
    Park, Y. H.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 3153 - 3155
  • [10] Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: A case report
    Garcia, Angelica
    Yi, Nam-Joon
    Lee, Kyoung Bun
    Lee, Jeong-Moo
    Choi, Young Rok
    Suh, Suk-Won
    You, Tae
    Lee, Kwang-Woong
    Park, June Dong
    Kang, Hyoung Jin
    Kim, Joon Gon
    Kang, Eun Kyeong
    Hong, Geun
    Suh, Kyung-Suk
    PEDIATRIC TRANSPLANTATION, 2014, 18 (07) : E240 - E245